Ras-ERK1/2 signaling in vascular smooth muscle cells (VSMCs) and in injured arteries. The recent study indicates that SM22␣ disruption can independently promote arterial inflammation through activation of reactive oxygen species (ROS)-mediated NF-B pathways. However, the mechanisms by which SM22␣ controls ROS production have not been characterized.
enzymatic complex, which is regulated by cytoplasmic subunits such as p47 phox . Multiple recent reports indicate that the p47 phox subunit of NADPH oxidase is the pivot factor in Ang II-stimulated ROS production in vascular cells. 8 -10 Ang II activates NADPH oxidases in VSMCs by inducing phosphorylation and membrane translocation of p47 phox and by de novo protein synthesis of p47 phox and other NADPH oxidase subunits. [11] [12] [13] This produces ROS and activates a myriad of other signaling events and transcription factors such as NF-B and AP-1. 13 The molecular and cellular actions of Ang II in cardiovascular diseases are almost exclusively mediated by Ang II type 1 receptors (AT 1 R). 1 The protein kinase C (PKC), as downstream of the AT 1 receptor, is shown to be essential in Ang II-accelerated ROS production via promoting of phosphorylation and membrane translocation of p47 phox . PKC␦ is one of the main isoforms in rat VSMCs. 14 However, no information is available regarding a role of PKC␦ in Ang II-mediated ROS production.
Despite increasing knowledge about the regulation of oxidative stress, the exact molecular mechanisms of functional protein governing ROS production in VSMCs have not yet been fully defined. The latest study has revealed that the disruption of smooth muscle (SM) 22␣, an actin-associated protein, induces vascular inflammation through activation of ROS-mediated NF-B pathways. 15 SM22␣ is a member of the calponin family, containing a calponin homology domain conserved from yeast to human. 16, 17 The known function of SM22␣ is to bundle and stabilize actin filaments, which is involved in actin filament assembly and cytoskeletal rearrangements. 18, 19 Although this protein is not required for the development and basal homeostatic function of SMCs in the developing mouse, 19 the role of SM22␣ may not be compensated under pathological conditions. Indeed, loss of SM22␣ in apolipoprotein E knockout (ApoE Ϫ/Ϫ ) mice results in increased atherosclerotic lesions with prominent macrophage infiltration, a marker of enhanced inflammation. 20 Our recent studies reveal that high expression of SM22␣ inhibits cell proliferation via blockade of the Ras-ERK1/2 signaling pathway in VSMCs and in injured arteries. 21 Because SM22␣ is an actin-associated protein, and NADPH oxidase activation may be affected by change in actin cytoskeleton organization, 22 cytoskeleton remodeling induced by disruption of SM22␣ in VSMCs may activate multiple ROS production machineries. 15 The precise mechanism of SM22␣ in controlling oxidative stress remains to be identified.
In this study, we sought to determine how SM22␣ disruption would activate ROS generation in VSMCs and characterize the molecular pathways involved. We show that both downregulation and phosphorylation of SM22␣ at serine 181 activate the PKC␦-p47 phox axis via its dissociation with PKC␦ and actin dynamics and mediate ROS production, which is associated with hypertrophy and hyperplasia of VSMCs in vitro and in vivo.
Methods
An expanded Materials and Methods section is available in the Online Data Supplement.
Rat cDNA of SM22␣ and its phosphorylation site mutants, S181D or S181A, was cloned into Ad/CMV/V5-DEST vectors (Invitrogen) to obtain the replication-defective adenovirus according to the manufacturer's instructions, named Ad-GFP-SM22␣, Ad-GFP-S181D, and Ad-GFP-S181A, respectively.
VSMCs were infected for 24 hours with the above adenovirus constructs, using a multiplicity of infection of 100. The hypertrophy and hyperplasia of VSMCs were examined by 5-bromo-2-deoxyuridine (BrdU) incorporation and protein synthesis, respectively. In rats, 28% pluronic F-127 gel (Sigma) containing the above adenovirus at a concentration of 10 9 pfu/mL was spread evenly around the outside of the left carotid arteries. After 2 days, the rats were reanesthetized and osmotic minipumps (Alzet 2ML4) were implanted subcutaneously in the midscapular region for either vehicle (saline) or Ang II at a rate of 750 g/kg per day.
Systolic blood pressure was measured on days 3 and 0 (basal) before pump implantation and every 3 to 6 days after implantation using a standard tail cuff (BP-2010A System, Softron). ROS level was measured by dihydroethidium (DHE) staining for superoxide and TBA assay for malondialdehyde (MDA), respectively.
Data are presented as meanϮSEM. A statistical analysis was performed using the Student t test. A value of PϽ0.05 was considered to be significant.
Results

Downregulation of SM22␣ Expression Increases Oxidative Stress in Ang II-Induced VSMCs
Over the past decade, experiments have demonstrated that Ang II is a potent stimulus for ROS generation and cell growth. 23 We showed that chronic treatment with Ang II (10 Ϫ7 mol/L) decreased the SM22␣ and SM ␣-actin levels and elevated expression of proliferating cell nuclear antigen protein (a marker of cell growth) in a time-dependent manner (Online Figure IA) , suggesting that Ang II induces the phenotypic remodeling from contractile to synthetic state and cell proliferation in VSMCs. Meantime, the results from DHE staining for superoxide and TBA assay for MDA, respectively, showed that ROS production was increased on Ang II treatment, with 2 peaks at 0.5 to 1 hour and 24 hours, respectively ( Figure 1A and Online Figure IB) , accompanied with the reduction of SM22␣ expression. These findings allow us to hypothesize that downregulation of SM22␣ expression may be associated with Ang II-induced oxidative stress in VSMCs. To test this hypothesis, specific SM22␣ small interference RNA (siSM22␣) was used to silence the expression of endogenous SM22␣ ( Figure 1B and 1C) . We showed that the knockdown of SM22␣ but not calponin enhanced ROS generation ( Figure 1C and Online Figure IC) , whereas overexpression of SM22␣ by infection of Ad-GFP-SM22␣ reduced it in VSMCs ( Figure 1C ). These results support our speculation that the downregulation of SM22␣ may be involved in Ang II-induced oxidative stress.
Disruption of SM22␣ Is Required for the Phosphorylation of P47 phox and ROS Production Induced by Ang II in VSMCs
It is well known that short-time stimulation of Ang II activates NADPH oxidases, mainly the p47 phox subunit, which generates ROS in VSMCs. 24 In the present study, we also demonstrated that the phosphorylation of p47 phox by Ang II was maximal at 10 minutes, and this effect was maintained over a 20-minute period ( Figure 2A ) in a manner similar to the change of ROS production. Also, the membrane translocation of p47 phox to the cell cortex on Ang II stimulation was discovered after subcellular fragmentation by Western blot and immunofluorescence, respectively (Online Figure IIA  and B) . On the basis of the establishment of a correlation between SM22␣ and ROS production (described above), we next investigated whether disruption of SM22␣ is required for p47 phox activation, using transfection with siSM22␣. The knockdown of SM22␣ significantly enhanced Ang II-induced phosphorylation of p47 phox and ROS generation (Figure 2B and Online Figure IIC) , whereas overexpression of SM22␣ by infection with Ad-GFP-SM22␣ decreased it (Figure 2C and Online Figure IID) . These data suggest that disruption of SM22␣ may be responsible for activation of p47 phox and ROS production in VSMCs, as previously shown. 15 Phosphorylation of SM22␣ at Ser181 Mediates P47 phox Activation and ROS Production Via Promoting Interaction of PKC␦ With P47 phox It has been known that Ang II-induced ROS production occurs in early and later 2 phases. 25, 26 To confirm the possible roles of SM22␣ in early oxidative stress, based on 3 potential phosphorylation sites in SM22␣, 16 an immunoprecipitation assay was performed to examine the phosphorylation of SM22␣. The results showed that phosphorylated SM22␣ accumulated in the short-time Ang II-stimulated VSMCs without affecting its overall expression ( Figure 3A) . Similar to the time course of Ang II-induced p47 phox phosphorylation, the phosphorylation of SM22␣ was maximal at 10 to 30 minutes and declined by 60 minutes after Ang II stimulation.
To determine the correlation between phosphorylation of SM22␣ and activation of p47 phox , VSMCs were infected by SM22␣ Ser181 site-mutant adenovirus, Ad-GFP-S181D (substitution of serine 181 to aspartic acid to mimic serine phosphorylation) and Ad-GFP-S181A (mutation 181 residue from serine to alanine to inhibit SM22␣ phosphorylation). Immunoprecipitation results showed that wild-type (WT) SM22␣ and S181A mutant significantly suppressed p47 phox phosphorylation induced by Ang II ( Figure 3B ). Similarly, the results from Western blot showed that the increased p47 phox in the membrane fraction on Ang II stimulation was abolished by overexpression of SM22␣ and S181A mutant, respectively ( Figure 3B ). These data indicate that phosphorylation of SM22␣ at Ser181 may facilitate p47 phox activation. Previous studies found that both SM22␣ and p47 phox could be phosphorylated by PKC in vitro and in vivo. 16, 24 To further elucidate the molecular mechanism by which the phosphorylation of SM22␣ mediates the activation of p47 phox , we focused on the relationship between SM22␣ and the signaling molecules p47 phox and PKC␦. Using coimmunoprecipitation, we discovered that PKC␦ was associated with SM22␣ but not p47 phox in quiescent VSMCs ( Figure 3C ). However, on Ang II stimulation for 10 minutes, PKC␦ was dissociated from SM22␣ and in turn interacted with p47 phox , which revealed an increased PKC␦ and p47 phox in the membrane fraction, with a concomitant increase in SM22␣ phosphorylation and phox activation. The similar changes were observed after Ang II stimulation for 24 hours, which decreased in cytosol PKC␦ and p47 phox with their membrane translocation ( Figure  3C ). Immunofluorescent staining further confirmed that PKC␦ translocated from the cytosol to cell periphery, where it colocalized with p47 phox after Ang II stimulation ( Figure  3D ). In the meantime, we also found that Ang II induced the increased perinuclear distribution of PKC␦ and p47 phox , consistent with the previous studies. 9, 27, 28 To verify the involvement of SM22␣ phosphorylation in direct activation of the PKC␦-p47 phox axis, low endogenous SM22␣ expressing cell, 293A cells were transfected with GFP-S181D, GFP-S181A, and WT constructs, respectively. PKC␦ was markedly associated with S181A and weakly bound to S181D (Online Figure IIIA) . The interaction of PKC␦ with p47 phox induced by Ang II was decreased in both WT-and S181A-expressed cells but not in S181D-transfected cells (Online Figure IIIB) . To confirm that the decreased interaction of SM22␣ with PKC␦ was due to SM22␣ phosphorylation, the glutathione S-transferase (GST) pull-down assay was next performed. PKC␦ in the whole-cell lysates from Ang II-induced VSMCs could be pulled down by GST-S181A fusion protein rather than GST-S181D (Online Figure IIIC) . Furthermore, the overexpression of WT SM22␣ and S181A mutant but not S181D decreased Ang II-induced ROS production ( Figure 3E ). Taken together, these data strongly suggest that phosphorylation of SM22␣ induced by Ang II activates the PKC␦-p47 phox pathway via release of PKC␦, subsequently facilitating the interaction of PKC␦ with p47 phox , which is responsible for early oxidative stress. Thus, we find a novel mechanism by which SM22␣ controls ROS production in the early stage.
Ang II induced the increasing interaction of PKC␦ with p47 phox , and ROS production was also discovered in human VSMCs from umbilical artery, along with the increase in the phosphorylation of p47 phox and SM22␣ (Online Figure IIID through F). These findings suggested that the disruption of SM22␣ facilitates the interaction between PKC␦ and p47 phox , which is involved in chronic oxidative stress induced by Ang II.
AT 1 R-PKC␦ Signaling Pathway Mediates Ang II-Induced Phosphorylation of SM22␣
To determine whether AT 1 R mediates Ang II-induced SM22␣ phosphorylation, we used the AT 1 R antagonist valsartan to block Ang II-induced AT 1 R activation. Valsartan significantly reduced Ang II-induced SM22␣ phosphorylation ( Figure 4A) . One of the key pathways linked to AT 1 R in VSMCs is the activation of PKCs, which activate multiple biological responses, including ROS production, inflammation, and cell growth. 24 It is known that SM22␣ Ser 181 is a potential phosphorylation site of PKC. 16 To verify the involvement of PKC in SM22␣ phosphorylation, VSMCs were stimulated with the PKC agonist phorbol myristate acetate (PMA) to activate PKC. We observed the increased SM22␣ phosphorylation in PMA-induced VSMCs ( Figure 4B ). We next examined whether the AT 1 R-PKC signaling pathway is associated with SM22␣ phosphorylation using selective inhibitors. We found that preincubation with Rottlerin, a PKC␦-selective inhibitor, significantly attenuated Ang IIinduced SM22␣ phosphorylation ( Figure 4C) . Moreover, Staurosporine, a potent broad inhibitor of PKCs, displayed an inhibitory effect similar to that in Rottlerin ( Figure 4C ). Alternately, knockdown of PKC␦ by small interference RNA (siRNA) also abolished Ang II-induced SM22␣ phosphorylation but did not affect AT 1 R phosphorylation ( Figure 4D ). To further determine that PKC␦ mediates phosphorylation of SM22␣, a selective inhibitor (Gö6976) of PKC ␣ and ␤ was used and showed a slight inhibitory effect on Ang IIstimulated SM22␣ phosphorylation compared with Rottlerin ( Figure 4E ). These data indicate that the AT 1 R-PKC␦ pathway mainly mediates Ang II-induced phosphorylation of SM22␣ in VSMCs. 
Downregulation of SM22␣ May Be Responsible for the Long-Term Effects of Ang II on Oxidative Stress Via Increasing Actin Dynamics in VSMCs
The actin cytoskeleton not only controls cell shape and motility but also plays an important role in many signaling pathways. 29 -31 It has only been demonstrated that PKC phosphorylation on Ser181 reduces SM22␣ binding to actin in vitro. 16 In the present study, we demonstrated that such phosphorylation actually occurs in VSMCs. In eukaryocyte, protein ubiquitination is generally dependent on its phosphorylation, which triggers the activity of E3 ubiquitin ligase. 32 For this, we first examined whether SM22␣ phosphorylation modulates its degradation. The results showed that Ang II induced SM22␣ ubiquitination with a peak at 4 hours in VSMCs, which occurred before downregulation of SM22␣ ( Figure 5A ). To determine whether the increased SM22␣ ubiquitination is dependent on its phosphorylation, VSMCs preincubated with the PKC␦-selective inhibitor Rottlerin were then stimulated by Ang II. Rottlerin inhibited Ang II-induced SM22␣ ubiquitination ( Figure 5B ). We also found phox before and after Ang II stimulation for 10 minutes by laser scanning confocal microscope (nϭ4). Bars: 25 m. E, DHE (2 mol/L) staining and TBA analysis in VSMCs infected with Ad-GFP, Ad-GFP-SM22␣, Ad-GFP-S181D, or Ad-GFP-S181A before (Ϫ) and after (ϩ) stimulation with Ang II for 10 minutes. Bar graphs show meanϮSEM values from 3 independent experiments (nϭ3). *PϽ0.05, **PϽ0.01 versus Ad-GFP (Ϫ).
that the ubiquitylation of SM22␣ significantly increased in VSMCs infected with Ad-GFP-S181D on Ang II stimulation, compared with Ad-GFP-S181A ( Figure 5C ). To verify this finding, 293 A cells were transfected with the indicated constructs and then treated with Ang II. We showed that S181D mutant but not S181A had an increase in ubiquitylation (Online Figure IVA) . These results suggest that Ang II-induced phosphorylation facilitates SM22␣ degradation via the ubiquitin-proteasome pathway.
Our studies and others have demonstrated that SM22␣ plays critical role in regulating and stabilizing the actin cytoskeleton. 18, 33, 34 Next, we investigated the relationships between downregulation of SM22␣ mediating actin dynamics and ROS production. VSMCs were treated with Ang II for 12, 24, and 48 hours, respectively, and the distribution of actin in the cytosolic soluble (Sol, G-actin) and cytoskeletal fractions (Csk, F-actin) was tested by Western blot. The interaction between p47 phox and PKC␦ markedly increased after Ang II treatment for 24 hours (Figure 3C ), parallel with the decreased Csk/Sol-actin ratio (Online Figure IVB) , suggesting that depolymerization of F-actin may facilitate the activation of the PKC␦-p47 phox pathway. To further confirm this argument, cytochalasin B (CB) was used to destroy the actin cytoskeleton. The depolymerization of the actin cytoskeleton resulted in the increased interaction of PKC␦ with p47 phox and activation of p47 phox in CB-pretreated VSMCs ( Figure 5D and Online Figure IVC) . In contrast, the actinstabilizing toxin jasplakinolide inhibited it (Online Figure  IVD and E) . The knockdown of SM22␣ also increased interaction of PKC␦ with p47 phox , accompanied with decreasing of the Csk/Sol-actin ratio (Online Figure IVF) . Taken together, Ang II-induced actin dynamics may be required for long-term effects of oxidative stress via degradation of SM22␣ by the ubiquitin-proteasome pathway.
Phosphorylation of SM22␣ Is Involved in Both Hypertrophy and Hyperplasia of VSMCs Via Increased ROS Generation In Vitro and In Vivo
To investigate the role of SM22␣ phosphorylation mediating oxidative stress in hypertrophy and proliferation of VSMCs in vitro and in vivo, we first tested BrdU incorporation and total protein amount per cell in VSMCs stimulated with Ang II. The BrdU incorporation and the total protein amount per cell increased after Ang II stimulation for 24 and 72 hours, respectively, which was decreased by overexpression of SM22␣ and S181A mutant ( Figure 6A) .
Furthermore, we directly examined the effects of SM22␣ phosphorylation on vascular hypertrophy and blood pressures under basal conditions and after treatment with Ang II (750 g/kg per day), after infection of the adenovirus constructs expressing WT and mutants of SM22␣. Systolic blood pressure was significantly increased in rats receiving Ang II plus the adenovirus constructs, compared with vehicle (Figure 6B and Online Table I ). The medial thickness and medial cross-sectional area of the carotid arteries were increased after Ang II infusion for 14 days, were significantly enhanced at 28 days in Ang II plus GFP and S181D overexpression, respectively, consistent with increasing of ROS generation after Ang II infusion for 14 days ( Figure 6C and 6D and Online Figure VA through C) . Using the balloon injury model of rat carotid arteries, we found the same trend that the phosphorylation of SM22␣ enhanced ROS generation and neointimal hyperplasia induced by injury, accompanied with increasing of BrdU incorporation ( Figure 6E and Online Figure VD through F) . Taken together, these results suggest that SM22␣ may play key roles in cellular hypertrophy and hyperplasia of VSMCs via modulating oxidative stress in vitro and in vivo. Thus, SM22␣ Ser 181 site may be an effective molecular target for prevention of hypertension and restenosis after angioplasty.
Discussion
SM22␣ directly binds to the actin cytoskeleton and induces actin bundling to facilitate the formation of cytoskeletal structure such as stress fibers. However, Sm22␣ Ϫ/Ϫ mice are viable, fertile, and exhibit no obvious phenotypic abnormalities. 19 For many years, its function was unknown.
In the present study, we demonstrated that the downregulation and mainly phosphorylation of SM22␣ were associated with Ang II-induced ROS production in VSMCs. Ang II induced the phosphorylation of SM22␣ at Ser 181 in an AT 1 R-PKC␦ pathway-dependent manner. Phosphorylated SM22␣ activated the PKC␦-p47 phox axis and promoted ROS generation via 2 distinct pathways. First, in early stimulation, the phosphorylation of SM22␣ at Ser 181 resulted in its dissociation from PKC␦, which promoted binding of p47 phox to PKC␦ and subsequently p47 phox activation. Second, the phosphorylation-accelerated SM22␣ ubiquitin-proteasome degradation mediated actin cytoskeletal remodeling, which may facilitate the translocation of the PKC␦ and PKC␦-p47 phox axis activation, ROS production, VSMC proliferation, and hypertrophy in a later stimulation. In addition, Ang II-induced medial hypertrophy and balloon injury-induced neointima formation were significantly suppressed by infection of SM22␣ S181A mutant in vivo, indicating that PKC␦-mediated phosphorylation of SM22␣ is involved in oxidative stress and vascular remodeling.
The present study verified that Ang II induced ROS production with 2 peaks: for 0.5 to 1 hour, and for 24 hours, inconsistent with the previous description. 25, 26 The possible explanation for such inconsistent findings may be due to the application of different methods to detect ROS production, because ROS could be generated by NADPH oxidases, xanthine oxidase, uncoupled nitric oxide synthase, and mitochondria in the vessel wall. 35 Our findings suggest that these 2 peaks are regulated by phosphorylated SM22␣ in different manners. Sequence analysis reveals that there are 3 potential phosphorylation sites in SM22␣ structure, including a PKC consensus target motif (S/T-X-R/K) at amino acids 181 to 183 and 2 CKII consensus target motifs (S/T-X-X-D/E) at amino acids 16 to 19 and 139 to 142. 16 The present study showed that the site at Ser181 could be phosphorylated by PKC␦, which is involved in PKC␦ activating p47 phox via release of PKC␦ in early stimulation of Ang II. The inhibition of the PKC␦ activity, using the specific inhibitor or siRNAmediated PKC␦ knockdown, effectively attenuated SM22␣ phosphorylation in VSMCs, suggesting that SM22␣ is a PKC␦ substrate in vivo.
It has also been reported that phosphorylation of calponin by PKC results in its dissociation from actin. 36 -39 SM22␣ has functions to similar to those of calponin in VSMCs, such as inhibition of phenotype remodeling VSMC from contractile to synthetic cells, 20 organization of actin filaments, 18, 40 regulation of the ERK signaling pathway, 21 and cell migration. 41 In the present study, importantly, we found that SM22␣ anchored PKC␦ to the cytoplasm in quiescent cells. In response to Ang II, PKC␦ phosphorylates SM22␣ at Ser 181, and the phosphorylated SM22␣ detached from PKC␦ and lost its inhibiting PKC␦ activity. The interactions of PKC with other proteins play an important role in the functions of PKC itself and the other proteins with which it interacts. 36 In this study, we also showed that phosphorylation of SM22␣ Ser181 is required for dissociation of SM22␣ from PKC␦.
In VSMCs, Ang II induces rapid translocation of p47 phox to the membrane, resulting in increased NADPH oxidase activity via activation of PKC through multiple pathways. 24 Recent evidence suggests that inhibition of the PKC␤ isoform blocks Ang II-induced production of ROS in VSMCs. 42 Thus far, it is rarely reported that PKC␦ phosphorylates p47 phox in Ang II-induced ROS production. To elucidate the significance of dissociation of phosphorylated SM22␣ from PKC␦ in Ang II-induced p47 phox activation, we examined the correlation between this dissociation and PKC␦-p47 phox axis activation. Unexpectedly, we found that PKC␦ was a main kinase for p47 phox activity in Ang II-stimulated VSMCs, and the phosphorylation of SM22␣ facilitated this axis activity via release of PKC␦. Interestingly, the nonphosphorylated mutant of SM22␣, S181A, inhibited PKC␦ translocation and p47 phox activation, although PKC␦ was activated by Ang II via AT 1 R. Studies from other laboratories have indicated that PKC activity is related to its subcellular localization. 43, 44 We speculated that the rate-limiting step in activation of p47 phox may be represented by the dissociation of phosphorylated SM22␣ from PKC␦, which then becomes phosphorylated and starts ROS production. PKC␦-mediated SM22␣ phosphorylation regulates the activity of itself, as well as its subcellular localization. Taken together, in vitro and in vivo data indicate that phosphorylation of SM22␣ by PKC␦ promotes activation of the PKC␦-p47 phox pathway. We therefore discovered a novel signaling pathway that governs ROS production down- stream of PKC. In addition, we also demonstrated that Ang II-induced phosphorylation of SM22␣ and ROS generation were AT 1 R-dependent, consistent with a previous report. 45 Our findings suggest a novel role of SM22␣ in rapid activation of p47 phox induced by Ang II. Thus, SM22␣ is regulated by PKC␦ and regulates PKC␦ activity as an adaptor protein that affects the oxidative stress of VSMCs.
SM22␣ directly binds to the actin cytoskeleton and induces actin bundling to facilitate the formation of cytoskeletal structure such as stress fibers. 16, 17, 41 The actin-bundling effect of SM22␣ may lead to a stable cytoskeleton. 33 Touyz et al have shown that Ang II induces p47 phox phosphorylation and translocation to membranes by modulating the actin cytoskeleton. 8, 22 Our data demonstrated that depolymerization of the actin cytoskeleton by cytochalasin B resulted in the increased interaction of PKC␦ with p47 phox in VSMCs. It seems plausible that the enhance of PKC␦-p47 phox activity by SM22␣ downregulation would be due, at least in part, to decreased actin cytoskeleton stability. In support of this possibility, we demonstrated an attenuated PKC␦-p47 phox activity in SM22␣-overexpressed VSMCs. The recent report indicates that there is correlation between NADPH oxidase activation and diminished stress fiber formation in PAC1 cells after Sm22␣ knockdown. 15 Activation of NADPH oxidase requires the membrane assembly of cytosolic p47 phox , p67 phox , p40 phox , and Rac2. 22, 46 It was reported that the actin cytoskeleton and associated proteins may affect this process. 22 Our study thus suggests that SM22␣ downregulation mediating actin dynamics is important for the later ROS production induced by Ang II in VSMCs.
We demonstrated for the first time that the delivery of SM22␣ and S181A significantly inhibited cross-sectional area with suppression of ROS production by Ang II in the carotid arteries, suggesting that SM22␣ is causally involved in medial hypertrophy in vivo, acting independently of changes in blood pressure. Ang II not only mediates hypertension and vascular hypertrophy but also is implicated in VSMC proliferation. In the current study, we showed that SM22␣ and mutant S181A inhibited Ang II-induced VSMC proliferation in vitro and in injury-induced neointimal hyperplasia to some extent in vivo. Taken together, the findings suggest that SM22␣ phosphorylation plays an important role in hypertrophy and proliferation of VSMCs.
In summary, phosphorylation of SM22␣ has dual roles in the regulation of PKC␦-p47 phox activity. In addition to its release of PKC␦, thus allowing p47 phox binding and catalysis, phosphorylated SM22␣ is dissociated from actin, leading to an unstable actin cytoskeleton, which is essential for PKC␦ translocation and p47 phox activation in Ang II-induced ROS production of VSMCs (Figure 7 ). SM22␣ is a novel PKC␦-regulating and PKC␦-regulated adaptor protein that affects hypertrophy and hyperplasia of VSMCs via modulating oxidative stress. Thus, our results provide the molecular evidence for previous reports indicating an important role for SM22␣ in oxidative stress of VSMCs during the development of hypertension and neointimal hyperplasia. 
